Pathogenesis of SLE Dermatitis - A Reflection of the Process in SLE Nephritis?

被引:12
作者
Fismen, Silje [1 ]
Rekvig, Ole Petter [2 ,3 ]
Mortensen, Elin Synnove [1 ,4 ]
机构
[1] Univ Hosp Northern Norway, Dept Pathol & Anat, N-9038 Tromso, Norway
[2] Univ Hosp Northern Norway, Dept Rheumatol, N-9038 Tromso, Norway
[3] Univ Tromso, Dept Biochem, Inst Med Biol, Fac Med, N-9037 Tromso, Norway
[4] Univ Tromso, Dept Pathol, Inst Med Biol, Fac Med, N-9037 Tromso, Norway
关键词
SLE; dermatitis; nephritis; nucleosomes; autoantibodies; apoptosis;
D O I
10.2174/157339707780619412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is an inflammatory autoimmune syndrome that may affect most organs in the body. Anti-dsDNA antibodies represent a classification criterion for SLE and are involved in lupus nephritis. Recently, the structures that bind lupus-related nephritogenic autoantibodies in vivo have been characterized by transmission electron microscopy (EM), immune-EM and co-localization immune-EM. By these methods, glomerular in vivo-bound autoantibodies were shown to co-localize with loci for binding of different experimental anti-chromatin antibodies, pointing at glomerular basement membrane-associated nucleosomes as target antigens. Lupus dermatitis has not been investigated in as much detail as lupus nephritis, but data indicate similarities between these two organ manifestations. The presence of granular antibody deposits at the dermo-epidermal junction suggests that the tissue injury is mediated by immune complexes. The deposits may be constituted by nucleosomes or chromatin and antibodies bound to them. The nucleosomes may be released locally or systemically from apoptotic cells; i.e. a process similar to that established for lupus nephritis. In this review we summarize current knowledge on immuno-pathological processes that are central in lupus nephritis, and discuss whether they may be similar to those occurring in lupus dermatitis.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 81 条
[1]   Activation/inactivation of the classical pathway of complement in non-lesional skin of patients with systemic lupus erythematosus [J].
Alahlafi, A ;
Wordsworth, P ;
Wojnarowska, F .
JOURNAL OF CUTANEOUS PATHOLOGY, 2005, 32 (08) :537-540
[2]   NUCLEOSOME-RESTRICTED ANTIBODIES ARE DETECTED BEFORE ANTI-DSDNA AND/OR ANTIHISTONE ANTIBODIES IN SERUM OF MRL-MP LPR/LPR AND +/+-MICE, AND ARE PRESENT IN KIDNEY ELUATES OF LUPUS MICE WITH PROTEINURIA [J].
AMOURA, Z ;
CHABRE, H ;
KOUTOUZOV, S ;
LOTTON, C ;
CABRESPINES, A ;
BACH, JF ;
JACOB, L .
ARTHRITIS AND RHEUMATISM, 1994, 37 (11) :1684-1688
[3]   Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L [J].
Aragane, Y ;
Kulms, D ;
Metze, D ;
Wilkes, G ;
Pöppelmann, B ;
Luger, TA ;
Schwarz, T .
JOURNAL OF CELL BIOLOGY, 1998, 140 (01) :171-182
[4]   Apoptosis in different cutaneous manifestations of lupus erythematosus [J].
Baima, B ;
Sticherling, M .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (05) :958-966
[5]   Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis [J].
Berden, JHM ;
Licht, R ;
van Bruggen, MCJ ;
Tax, WJM .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (03) :299-306
[6]   Lupus nephritis - Discussion [J].
Berden, JHM ;
Madias, NE ;
Broumand, B ;
Klinger, M ;
Sonkodi, S ;
Nayak, KS ;
Hruby, Z .
KIDNEY INTERNATIONAL, 1997, 52 (02) :538-558
[7]  
Berden JHM, 2003, NETH J MED, V61, P233
[8]   THE APPLICATION OF THE FLUORESCENT ANTIBODY TECHNIC TO THE INVESTIGATION OF LUPUS ERYTHEMATOSUS AND VARIOUS DERMATOSES [J].
BURNHAM, TK ;
NEBLETT, TR ;
FINE, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1963, 41 (06) :451-456
[9]   AUTOANTIGENS TARGETED IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARE CLUSTERED IN 2 POPULATIONS OF SURFACE-STRUCTURES ON APOPTOTIC KERATINOCYTES [J].
CASCIOLAROSEN, LA ;
ANHALT, G ;
ROSEN, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1317-1330
[10]   The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity [J].
Chen, XG ;
Wolin, SL .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (04) :232-239